VDV Pharma SRL
1.5 FTEThe score of VDV Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +23 % Total assets +172 % Headcount (avg FTE) +36 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VDV Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 17 Nov 2025
- Year ended 30 Jun 2024filed on 07 Jan 2025
- Year ended 30 Jun 2023filed on 23 Jan 2024
- Year ended 30 Jun 2022filed on 12 Dec 2022
- Year ended 30 Jun 2021filed on 04 Jan 2022
VDV Pharma's financial analysis
- Solvency13.3%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VDV Pharma
VDV Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0750.740.804
- VAT number
- BE0750740804
- Peppol
- Registered · 0208:0750740804 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jul 2020
- Registered office
- 1030 Schaerbeek
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 17 Nov 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
VDV Pharma (SRL) has been based in Schaerbeek since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 66,371 € and equity of 201,427 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.3%, below the median of its sector (37.6%).
Companies similar to VDV Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apoteek Jespers - Cuijpers Retail sale of pharmaceutical products Anderlecht · balance sheet €1.72m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- PCMA Retail sale of pharmaceutical products Chaudfontaine · balance sheet €1.53m
- Vanschoonbeek Farma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.50m
- Apotheek DE Wilde ZEE Retail sale of pharmaceutical products Antwerp · balance sheet €1.48m
- Lenans Retail sale of pharmaceutical products Mons · balance sheet €1.57m
Frequently asked questions about VDV Pharma
What is the revenue of VDV Pharma?
VDV Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VDV Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0750740804 for VDV Pharma, if the company is VAT-registered. Its company number (CBE) is 0750.740.804.
Where is the registered office of VDV Pharma?
According to the CBE register, the registered office of VDV Pharma is in 1030 Schaerbeek.
What is the equity of VDV Pharma?
At the close of the 2025 financial year, the equity of VDV Pharma amounts to 201,427 €, a solvency of 13.3% of total assets.
How many people work at VDV Pharma?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages VDV Pharma?
The register lists 1 active mandates at VDV Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VDV Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →